PTC Therapeutics Inc (PTCT)
42.96
-0.22
(-0.51%)
USD |
NASDAQ |
Nov 07, 16:00
43.00
+0.04
(+0.09%)
After-Hours: 20:00
PTC Therapeutics Revenue (Annual): 937.82M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 937.82M |
| December 31, 2022 | 698.80M |
| December 31, 2021 | 538.59M |
| December 31, 2020 | 380.77M |
| December 31, 2019 | 306.98M |
| December 31, 2018 | 264.73M |
| December 31, 2017 | 194.39M |
| Date | Value |
|---|---|
| December 31, 2016 | 82.70M |
| December 31, 2015 | 36.77M |
| December 31, 2014 | 25.24M |
| December 31, 2013 | 34.70M |
| December 31, 2012 | 28.78M |
| December 31, 2011 | 98.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
306.98M
Minimum
2019
937.82M
Maximum
2023
572.59M
Average
538.59M
Median
2021
Revenue (Annual) Benchmarks
| Pfizer Inc | 58.50B |
| Vertex Pharmaceuticals Inc | 9.869B |
| BridgeBio Pharma Inc | 9.303M |
| Cassava Sciences Inc | -- |
| Crinetics Pharmaceuticals Inc | 4.013M |